CLINICAL TRIAL / NCT04857372 - UChicago Medicine

Study criteria for patients ≥18 with advanced mesothelioma or solid tumors, requiring informed consent, specific genetic alterations, and measurable lesions. Excludes recent anti-cancer therapies, insufficient organ function, and active COVID-19. Includes willingness for tumor biopsies.